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demonstrate that such activity is consistent over time and provide further evidence that deep brain
stimulation is associated with its suppression. However, the extent to which beta synchrony has a
mechanistic (rather than epiphenomenal) role in parkinsonism remains unclear, and the suppression of this
activity by deep brain stimulation is contentious. This commentary discusses the evidence for and against a
role for excessive beta synchrony in mediating the parkinsonian phenotype and in providing a possible
mechanism to explain the therapeutic effects of deep brain stimulation in Parkinson's disease.
© 2009 Elsevier Inc. Open access under CC BY license.What goes wrong to cause motor impairment in Parkinson's
disease? One way to answer this is to record neuronal activity
directly from the basal ganglia of afﬂicted patients or of animals
deliberately made parkinsonian through the use of selective toxins.
The last few decades have seen blame shift from altered discharge
rates to altered discharge patterns and now to excessive synchro-
nisation of activity across populations of neurons. The latter leads to
summation of electrical ﬁelds which can be picked up as undula-
tions of the local ﬁeld potential and may even be recorded through
the macroelectrodes used for therapeutic deep brain stimulation
(DBS). The paper by Bronte-Stewart et al. (2009) adds to the
growing evidence that excessive and oscillatory synchronisation
occurs in the basal ganglia in Parkinson's disease and that this has a
predilection for the beta frequency band centred around 20 Hz.
Bronte-Stewart and colleagues recorded local ﬁeld potentials from
the subthalamic nucleus in patients undergoing surgery for deep
brain stimulation of this target, an effective treatment of Parkinson's
disease and demonstrated that oscillatory activity was prominent in
the beta band, and that this was a consistent phenomenon over
many minutes of recording. Having established this they went on to
explore whether deep brain stimulation might act by suppressing
this pathological activity.
Herein lays a problem. Therapeutic DBS is performed at very high
frequencies (N100 Hz) and at voltages that are huge compared to the
spontaneous beta activity in the local ﬁeld potential. Accordingly, it license.has proven very difﬁcult to derive useful ﬁeld potential recordings
during DBS. All is not lost, however, as many patients with Parkinson's
disease experience clinical beneﬁt that outlasts the period of DBS by
seconds to minutes. Bronte-Stewart and colleagues cleverly recorded
during this period, with the expectation that beta activity might be
suppressed (Wingeier et al., 2006), and in their current paper they
develop this line, demonstrating that suppression occurs and its
duration can be extended by longer periods of DBS. Although the level
of beta suppressionwas not correlatedwith clinical state in their study
due to the practical constraints of recordings being made in the
operating theatre, their ﬁndings are complemented by those in
another recent report, where suppression of beta activity following
cessation of DBS was also demonstrated to correlate with the degree
of residual motor improvement (Kühn et al., 2008).
Nevertheless, these ﬁndings remain contentious, with a variety of
mechanisms being proffered to explain the beneﬁcial effects of DBS
(Hammond et al., 2008). The group of Priori in Milan have, in
particular, questioned whether DBS works by suppressing beta
synchrony. They failed to ﬁnd any consistent suppression in beta
activity after the cessation of DBS (Priori et al., 2006). It might be
possible to dismiss their ﬁndings on the basis that they averaged local
ﬁeld potential activity over too long a period following cessation of
DBS, as argued by Bronte-Stewart et al. (2009), but for the results of
their follow-up study. In the latter, they, through a feat of ampliﬁer
design (Rossi et al., 2007), were able to record local ﬁeld potential
activity actually during DBS. Overall, they found no suppression of
beta activity, but not all their patients had a peak in this frequency
band at baseline (Rossi et al., 2009), so that DBS could not suppress
beta any further. One reason for the absence of a baseline beta peak
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known to suppress beta activity (Hammond et al., 2007), another may
be that some of their patients had diminished beta activity associated
with the temporary ‘stun’ effect that may be seen after surgery, and
which is discussed later.
The effect of DBS on beta activity should be seen as part of a wider
debate as to whether beta synchrony mediates parkinsonism. Several
reports have shown a correlation between the levodopa-induced
suppression of beta activity and levodopa-induced improvement in
bradykinesia and rigidity (Kühn et al., 2006; Weinberger et al., 2006;
Ray et al., 2008; Kühn et al., 2008), and yet these only provide
evidence by association. There have been additional attempts to show
a more causal link by directly stimulating the subthalamic nucleus at
20 Hz instead of the more usual therapeutic frequencies (N100 Hz) in
parkinsonian patients chronically implanted with DBS electrodes
(Chen et al., 2007; Eusebio et al., 2008). Although these conﬁrm the
predicted slowing of motor performance, the effects are small and of
the order of about a 10% slowing in ﬁnger tapping.
The relatively modest effect of direct stimulation may be ascribed
to various factors: the failure to mimic the pathological state through
the delivery of only one synchronising discharge per cycle of the 20 Hz
rhythm, a ceiling effect of beta synchrony, given that tested patients
have had advanced Parkinson's disease and have been withdrawn
overnight from their dopaminergic therapy, or a single site interven-
tion in an extended loop that ordinarily shows excessive beta
synchrony at all sampled levels (Brown et al., 2001; Williams et al.,
2002; Lalo et al., 2008). But themodest effects also raise the possibility
that the bulk of the parkinsonian state is not mediated by beta
synchrony at all. Certainly, there is now general consensus that this
activity is not causally linked to parkinsonian tremor (Amirnovin et
al., 2004; Kühn et al., 2006; Weinberger et al., 2006; Ray et al., 2008;
Kühn et al., 2009). In addition, there is no correlation between beta
synchrony in the subthalamic nucleus and the UPDRS motor score
recorded off dopaminergic therapy (Weinberger et al., 2006; Ray et al.,
2008). So, at best, beta synchrony seems to relate to that portion of the
bradykinetic-rigid state that can be reversed by dopaminergic therapy
and that is therefore likely to improve with subthalamic nucleus DBS
(Charles et al., 2002). As Parkinson's disease becomes more advanced,
therapy induced reversal of parkinsonism is incomplete so that even
on combined drug therapy and subthalamic nucleus DBS, United
Parkinsons Disease Rating Scale (UPDRS) motor scores are generally
around 15–20 in chronically stimulated patients (Rodriguez-Oroz et
al., 2005). At the other end of the scale, it is also uncertain whether
beta synchrony relates to very early parkinsonian motor impairment.
As patients at this stage do not undergo functional neurosurgery,
recordings of synchronised activity have to be derived from animal
models of parkinsonism and these suggest that the onset of prominent
synchrony is delayed, arguably beyond the appearance of the very ﬁrst
motor deﬁcits (Leblois et al., 2007; Mallet et al., 2008a).
Another possible argument against a mechanistic role for beta
synchrony in parkinsonism is the fact that aminority of patients (none
in the paper of Bronte-Stewart et al. 2009) have very little beta power
in their subthalamic local ﬁeld potentials when recorded several days
after implantation, in the interval between the latter and further
surgery to introduce and connect a subcutaneous battery and
stimulator. Our experience is that such patients have prominent
stun effects, in other words temporary post-operative amelioration of
parkinsonism even before stimulation and which often makes the full
efﬁcacy of DBS difﬁcult to establish during the immediate post-
operative period. The stun effect is believed to be due to local trauma
and oedema, and there is evidence to link intra-operative stun effects
with partial beta suppression (Chen et al., 2006a). Nevertheless, no
study has explicitly sought a relationship between the post-operative
stun effect and loss of beta synchrony.
How might excessive neuronal synchronisation in the beta band
compromisemotor processing leading tomotor impairment? A recentstudy in an animal model of parkinsonism in which there is also
pathological beta activity has explored this (Mallet et al., 2008a). The
study examined themutual information between subthalamic nucleus
neuronal ensembles in 6-hydroxy-dopamine midbrain lesioned
rodents and found this to be signiﬁcantly increased as compared to
control animals. In this instance mutual information implies that
information channels are being squandered on the same message, so
that the capacity for information encoding and therefore processing
across thewhole systembecomes smaller in parkinsonian animals. But
how can this be reconciled with another recent report that sub-
thalamic nucleus DBS using therapeutic parameters leads to a severe
reduction in entropy and hence information coding capacity in single
neurons in the pallidumand thalamus (Dorval et al., 2008)?Maybe the
solution can be found in the old ‘noisy signal’ hypothesis (see Brown
and Eusebio, 2008). The implication is that in the parkinsonian state
only partial processing is possible in the basal ganglia and this kind of
activity effectively acts as a disruptive ‘noisy signal’ and is worse than a
ﬁxed and unfamiliar patterning of activity when passed on to other
processing units like the cortex. High frequency DBS acts to override
this functionally deleterious partial processing, replacing it with a
highly organised, very low entropy, discharge pattern which mirrors
the DBS regimen and is less disruptive to other sites. In other words
high frequency DBS replaces a noisy signal with a less disruptive one.
Whether the new pattern is innocuous or just not quite as bad is
another question (Chen et al., 2006b).
Another unresolved question is whether there is something
especially important about certain frequencies of pathologically
synchronised oscillation or whether it is the oscillatory synchronisa-
tion per se, rather than the precise frequency that is more relevant.
Most patients show evidence of synchronisation in the beta frequency
band, but this tells us more about the resonance frequencies of circuits
in the absence of dopaminergic input than whether synchronisation
with a lower or higher frequencymight be just as pathogenic if it were
to occur. Indeed, one report suggests that within certain limits (8–
35 Hz), changes in synchronisation rather than frequency correlate
better with levodopa-induced improvement in bradykinesia and
rigidity (Kühn et al., 2009). At even higher frequencies, however,
there seems to be no antikinetic effect, but rather a possible favouring
of movement (Brown, 2003).
Finally, the very existence of DBS after-effects on beta-activity, as
well as the intriguing observation that a longer duration of DBS leads
to a longer period of beta suppression, deserves further comment.
Effects that persist over tens of seconds or longer suggest that the
overriding of pathological patterning by DBS may be insufﬁcient to
explain all responses to this treatment and implies the existence of
plasticity phenomena in the basal ganglia – cortical network. Relevant
in this regard is the evidence of synaptic plasticity occurring in
cortico-striatal transmission during high-frequency stimulation of the
subthalamic nucleus in a rat model of Parkinson's disease (Gubellini et
al., 2006). Yet, not all patients experience clinical after-effects after
DBS, and in those that do there is a progressive and sequential return
of different symptoms after the discontinuation of stimulation
(Temperli et al., 2003). Together these observations argue for a
variety of pathophysiological mechanisms in Parkinson's disease,
which differentially contribute to separate parkinsonian features.
In summary, beta synchrony may relate to some but not all
elements of motor impairment in Parkinson's disease, and the jury is
still out on its quantitative importance and the means by which it
might disturb motor processing. One thing that seems reasonably
clear, however, is that beta synchrony is a good biomarker of the
established akinetic-rigid state in both patients (Hammond et al.,
2007) and many animal models of parkinsonism (Sharott et al., 2005;
Costa et al., 2006; Mallet et al., 2008a,b). As such it may be a useful
surrogate marker in pharmacological studies and in closed loop DBS
protocols. In the latter case, detection of beta activity in the
subthalamic local ﬁeld potential could be used to drive feedback
3A. Eusebio, P. Brown / Experimental Neurology 217 (2009) 1–3control of stimulation, where the primary purpose of this is to treat
bradykinesia and rigidity, rather than tremor. This could save on
battery life, limit side-effects and also save programming time Jensen
et al., 2008. The paper by Bronte-Stewart and colleagues adds to the
growing evidence that beta synchrony is a consistent feature of
parkinsonism and suppressed by DBS, helping pave the way for closed
loop stimulation in the future.
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